ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 178 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $143,187,000 | +47.7% | 7,803,131 | -0.0% | 0.18% | +29.0% |
| Q4 2018 | $96,951,000 | -35.2% | 7,806,082 | +0.0% | 0.14% | -20.7% |
| Q3 2018 | $149,637,000 | +40.9% | 7,805,769 | -0.1% | 0.17% | +37.0% |
| Q2 2018 | $106,217,000 | +88.7% | 7,810,039 | +0.0% | 0.13% | +81.4% |
| Q1 2018 | $56,293,000 | +142.8% | 7,807,644 | +23.9% | 0.07% | +150.0% |
| Q4 2017 | $23,184,000 | +78.5% | 6,300,000 | +110.0% | 0.03% | +75.0% |
| Q3 2017 | $12,990,000 | +167.3% | 3,000,000 | 0.0% | 0.02% | +166.7% |
| Q2 2017 | $4,860,000 | -12.4% | 3,000,000 | 0.0% | 0.01% | -14.3% |
| Q1 2017 | $5,550,000 | +19.4% | 3,000,000 | 0.0% | 0.01% | +16.7% |
| Q4 2016 | $4,650,000 | -78.9% | 3,000,000 | 0.0% | 0.01% | -78.6% |
| Q3 2016 | $22,050,000 | +38.2% | 3,000,000 | 0.0% | 0.03% | +33.3% |
| Q2 2016 | $15,960,000 | – | 3,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |